Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Fresenius Medical Care unveils Malaysia's first Peritoneal Dialysis products Manufacturing Plant

SEREMBAN, MALAYSIA -- (Marketwired) -- 09/14/17 -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, expanded its regional manufacturing plant in Bandar Enstek, Malaysia. Dato' Seri Dr. Chen Chaw Min, Secretary General of the Malaysian Ministry of Health graced the opening ceremony.

The plant is a state-of-the-art facility and will be Fresenius Medical Care's regional manufacturing hub for Southeast Asia. In addition to supplying high-quality haemodialysis concentrates and disinfectants, the plant produces Peritoneal Dialysis (PD) products necessary for advanced Continuous Ambulatory PD (CAPD) treatment.

"Malaysia with its positive business environment, skilled workforce, and strategic geographic location provides a natural choice for a regional manufacturing plant," said Harry De Wit, CEO Fresenius Medical Care Asia Pacific. "This marks an important milestone for Fresenius Medical Care and Malaysia, reinforcing our lifelong commitment to dialysis patients, and strengthening local healthcare capabilities for the future."

With about 43,000 dialysis patients in Malaysia(1) providing excellent renal care is of critical importance. Peritoneal Dialysis (PD) is a form of dialysis that uses the natural lining of the patient's abdomen to filter waste from the blood. The patients can perform PD in the comfort of their home.

Fresenius Medical Care's investment in this project will have a significant positive impact on the local economy. Plans to further expand the product portfolio and production capacity for local and regional markets are already in place.

"The Ministry of Health is committed to the Economic Transformation Programme in focussing on promoting investment in the National Key Economic Area (NKEA) of health care. The Fresenius Medical Care plant manufacturing high quality haemodialysis and peritoneal dialysis fluids while using the latest technology is part of this programme," Dato' Seri Dr. Chen Chaw Min added.

The plant in Bandar Enstek is the second plant of Fresenius Medical Care in Malaysia. At Ipoh the company produces Water Treatment Systems to ensure high water quality essential for dialysis.

(1) Based on the latest Preliminary Statistics of the Malaysian Dialysis and Transplant Registry (2015) and an average of 8% per annum increase of dialysis patients

ABOUT FRESENIUS MEDICAL CARE
Fresenius Medical Care is the world's largest provider of products and services for individuals with renal diseases of which around 3 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,690 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 315,305 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FRANKFURT: FME) and on the New York Stock Exchange (NYSE: FMS).

DISCLAIMER:
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3168538
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3168541
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3168544
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3168547
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3168550

Dr. Alexandra Villar
Marketing Communications
Asia-Pacific

Fresenius Medical Care
Level 3, 61 Lavender Street
Milsons Point, Sydney, NSW 2061
Australia
+61 2 9466 8020
Email Contact
www.freseniusmedicalcare.com

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Cloud Developer Stories
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in th...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment b...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitiga...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President a...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE